Clene Inc. Operating Cash Flow
Clene Inc. (CLNN) reported Operating Cash Flow of -$7.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Clene Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.59M.
- Clene Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.53M.
- Clene Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.80M.
- Clene Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.99M.
- Clene Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$18.55M.
- Clene Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$21.33M.
- Clene Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$30.17M.
- Clene Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$39.01M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$7.12M 10-Q · filed 2026-08-14 | -$11.91M derived: sum of 3 quarters · filed 2026-08-14 | -$15.91M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$4.53M 10-Q · filed 2026-05-14 | -$9.33M derived: sum of 2 quarters · filed 2026-05-14 | -$13.32M derived: sum of 3 quarters · filed 2026-05-14 | -$18.06M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$8.79M derived: sum of 2 quarters · filed 2026-03-17 | -$13.54M derived: sum of 3 quarters · filed 2026-08-14 | -$18.55M 10-K · filed 2026-03-17 |
| 2025-09-30 | -$3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$8.74M derived: sum of 2 quarters · filed 2026-08-14 | -$13.75M 10-Q · filed 2025-11-13 | -$18.61M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$9.76M 10-Q · filed 2026-08-14 | -$14.62M derived: sum of 3 quarters · filed 2026-08-14 | -$17.64M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$5.01M 10-Q · filed 2026-05-14 | -$9.88M derived: sum of 2 quarters · filed 2026-05-14 | -$12.90M derived: sum of 3 quarters · filed 2026-05-14 | -$19.25M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$7.89M derived: sum of 2 quarters · filed 2026-03-17 | -$14.24M derived: sum of 3 quarters · filed 2026-03-17 | -$21.33M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$9.38M derived: sum of 2 quarters · filed 2025-11-13 | -$16.46M 10-Q · filed 2025-11-13 | -$23.63M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$6.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$13.44M 10-Q · filed 2025-08-14 | -$20.61M derived: sum of 3 quarters · filed 2025-08-14 | -$27.37M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$7.08M 10-Q · filed 2025-05-07 | -$14.25M derived: sum of 2 quarters · filed 2025-05-07 | -$21.01M derived: sum of 3 quarters · filed 2025-05-07 | -$28.04M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$13.93M derived: sum of 2 quarters · filed 2025-03-24 | -$20.95M derived: sum of 3 quarters · filed 2025-03-24 | -$30.17M 10-K · filed 2025-03-24 |
| 2023-09-30 | -$6.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$13.78M derived: sum of 2 quarters · filed 2024-11-13 | -$23.00M 10-Q · filed 2024-11-13 | -$30.71M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$7.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$16.24M 10-Q · filed 2024-08-07 | -$23.95M derived: sum of 3 quarters · filed 2024-08-07 | -$32.44M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$9.22M 10-Q · filed 2024-05-08 | -$16.93M derived: sum of 2 quarters · filed 2024-05-08 | -$25.41M derived: sum of 3 quarters · filed 2024-05-08 | -$35.15M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$7.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$16.20M derived: sum of 2 quarters · filed 2024-03-13 | -$25.93M derived: sum of 3 quarters · filed 2024-03-13 | -$39.01M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$8.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$18.21M derived: sum of 2 quarters · filed 2023-11-07 | -$31.30M 10-Q · filed 2023-11-07 | -$40.90M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$9.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$22.81M 10-Q · filed 2023-08-14 | -$32.42M derived: sum of 3 quarters · filed 2023-08-14 | -$39.73M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$13.08M 10-Q · filed 2023-05-12 | -$22.69M derived: sum of 2 quarters · filed 2023-05-12 | -$30.00M derived: sum of 3 quarters · filed 2023-05-12 | -$38.55M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$9.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$16.91M derived: sum of 2 quarters · filed 2023-03-13 | -$25.46M derived: sum of 3 quarters · filed 2023-03-13 | -$34.62M 10-K · filed 2023-03-13 |
| 2021-09-30 | -$7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$15.86M derived: sum of 2 quarters · filed 2022-11-07 | -$25.02M 10-Q · filed 2022-11-07 | -$30.83M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$8.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$17.71M 10-Q · filed 2022-08-15 | -$23.52M derived: sum of 3 quarters · filed 2022-08-15 | -$31.24M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$9.16M 10-Q · filed 2022-05-09 | -$14.97M derived: sum of 2 quarters · filed 2022-05-09 | -$22.69M derived: sum of 3 quarters · filed 2022-05-09 | -$24.84M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$13.53M derived: sum of 2 quarters · filed 2022-03-11 | -$15.68M derived: sum of 3 quarters · filed 2022-03-11 | -$18.93M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$7.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$9.87M derived: sum of 2 quarters · filed 2021-11-08 | -$13.12M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$5.40M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | -$3.25M 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | -$13.20M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |